Foot-and-mouth disease (FMD) is a contagious viral disease affecting cloven-hoofed livestock, principally cattle, pigs, sheep, and goats. The 2001 outbreak in From the Institute for Animal Health, Pirbright Laboratory, Pirbright, Woking, Surrey, UK (King, Ferris, Shaw, Reid, Hutchings), Foreign Animal Disease Diagnostic Laboratory, National Veterinary Services Laboratories, USDA/APHIS, Plum Island Animal Disease Center, Greenport, NY (Giuffre, Robida, Beckham), and Tetracore Inc., Gaithersburg, MD (Callahan, Nelson) . Current address Beckham): Department of Homeland Security, Plum Island Animal Disease Center, Greenport, NY. 1 Corresponding Author: Donald P. King, Institute for Animal Health, Pirbright Laboratory, Ash Road, Pirbright, Woking, Surrey, GU24 0NF, UK. donald.king@bbsrc.ac.uk the United Kingdom highlighted the devastating impact of FMD in a country previously free from the disease. This outbreak lasted for approximately 7 months, requiring the slaughter of 6.5 million animals for its control, and is estimated to have cost £8 billion to the UK economy. Rapid and accurate diagnosis plays an important role for the implementation of effective measures to control the spread of disease. The causative agent, FMD virus (FMDV), is a highly variable RNA virus that exists as 7 immunologically distinct serotypes, which in most cases can be further subdivided into a number of topotypes. 5 Recently, realtime reverse transcription-polymerase chain reaction (rRT-PCR) assays 2,6-9 have been developed with the capability of detecting FMDV in a variety of sample matrices. These assays characteristically possess both high analytical sensitivity and high specificity. The ability to detect diverse FMDV strains (pan-reactivity) is an additional requirement for any routine FMD diagnostic assay. Although many of the published rRT-PCR assays are reported to be able to recognize members of all 7 FMDV serotypes, detailed evaluation of diagnostic sensitivity (D-SN) in direct comparison with other diagnostic methods such as virus isolation (VI) and antigen-enzyme-linked immunosorbent assay (Ag-ELISA) has currently been published for only 1 rRT-PCR assay. 10 This previous study concluded that the rRT-PCR method used had superior sensitivity to established diagnostic methods, for FMDV was detected in 18% more samples compared with VI and Ag-ELISA combined. 10 As part of the on-going validation for molecular methods, the aim of this current investigation was to compare in parallel the ability of 2 rRT-PCRs to detect a diverse selection of FMDV isolates. These assays, both in routine use by national reference laboratories, were designed to target 2 different conserved regions of the FMD viral genome: the internal ribosomal entry site located in the 5Ј untranslated region (5ЈUTR) 8 and viral RNA polymerase (3D). 2 The laboratory work was performed during 2004 by staff from the Foreign Animal Disease Diagnostic Laboratory (FADDL, USDA/ APHIS, Plum Island Animal Disease Center, Greenport, NY) and the Institute for Animal Health (IAH, Pirbright, Woking, Surrey, UK) using samples of epithelial tissue (n ϭ 394) submitted to the FAO World Reference Laboratory for FMD (IAH, Pirbright).
The epithelial tissues were collected from suspect FMDV cases during a 40-year period from 69 countries. Vesicular epithelial tissue is the preferred sample for diagnosis from infected animals because it is rich in virus during the acute stage of disease. Samples were selected from available material to ensure adequate coverage of the inter-and intratypic genetic variation of FMDV. In 81.2% (320 of 394) of cases, epithelial suspensions (ES) were prepared 3 at the time of sample receipt and were stored in the interim at Ϫ80ЊC, whereas the remainder were processed at a later date. The suspensions had been previously assayed for FMDV by using VI and Ag-ELISA. 3 The Ag-ELISA was also used to confirm the presence of FMDV in VI samples showing cytopathic effects. 3 The archived samples used in the study covered all 7 FMDV serotypes: 181 type O, 56 type A, 31 type Asia 1, 13 type C, 19 type SAT 1, 24 type SAT 2, and 7 type SAT 3. Suspect samples where no FMDV had been detected by VI or Ag-ELISA (classified as ''no virus detected'' [NVD; n ϭ 63]) were also examined.
Original ES stored at Ϫ80ЊC were used as the starting material for RNA extraction. Template RNA was prepared a from 140 l of the ES and eluted in 40 l. A total of 2.5 l of RNA was tested by a commercial 1-step rRT-PCR assay targeting 3D b,c as previously described. 2 The RNA samples were frozen at Ϫ80ЊC until tested with a second rRT-PCR targeting the 5ЈUTR. 8 Briefly, cDNA was synthesised d with 6 l of RNA in a total reaction volume of 15 l as previously described. 9 Polymerase chain reactions were prepared by using a robot e with 7 l of cDNA, TaqMan mastermix f and primers and probe. Amplification conditions g used were as previously described. 9 Preliminary experiments indicated that a single freeze-thaw of the RNA template did not consistently affect the cycle threshold (C T ) values obtained by more than 1 cycle in the 5ЈUTR rRT-PCR (data not shown). A positive control consisting of pooled RNA extracted from the FMDV reference strain O 1 Manisa (TUR 8/69) was included in every assay run.
A comparison of the rRT-PCR results for 394 ES are shown in Fig. 1 separated into the individual FMDV serotypes (and NVD) and summarized for all the samples tested in Fig. 2 . The C T used to designate positive samples was different between the 2 assays: Ͻ40 for the 5ЈUTR assay 10 and Ͻ45 for the rRT-PCRtargeting FMDV 3D assay. 2 Cycle threshold values falling between those of the diagnostic cut-off and absolute negative of the rRT-PCR (no C T ) were designated as borderline (shaded gray area on Figs. 1, 2).
There was agreement in the diagnostic result (either positive or NVD) produced between the 2 rRT-PCR assays for 88.1% (347 of 394) of the ES. These 347 samples consisted of 322 ES that were positive in both rRT-PCRs and 25 ES where both assays failed to detect FMDV. Of concern, the comparison between the 2 tests also highlighted 19 FMDV isolates (13 for the 5ЈUTR and 6 for the 3D assay; Fig. 2 ), which failed to produce a signal in one assay but gave a positive signal in the other assay. The region of the FMDV genome targeted was sequenced for 12 selected isolates to elucidate the reason why these viruses failed to generate a signal in the rRT-PCR. Fragments encompassing the diagnostic target were amplified by RT-PCR with primers 5Ј-CGT CHG CGC ACG AAA CGC-3Ј and 5Ј-RCG ATR AAR CAG TCR GTY R-3Ј for the 5ЈUTR or 5Ј-GAC AAA GGT TTT GTT CTT GGT CA-3Ј and 5Ј-TCA CCG CAC ACG GCG TTC A for the 3D region. 7 Polymerase chain reaction products were directly sequenced on both strands. h Sequence analysis revealed virus isolates with nucleotide substitutions that could explain a failure of the rRT-PCR. Ten serotype O viruses were missed by the 5ЈUTR assay. These consisted of closely related isolates collected from Wales during the 2001 epidemic in the United Kingdom. Identical sequences were obtained for 2 of these isolates. As reported elsewhere, 4 the failure of the assay can be explained by 3 nucleotide substitutions in the TaqMan probe region. The 3 remaining samples (A GHA 4/96, A BKF 2/94, and NVD GHA 2/2002) completely missed by the 5ЈUTR assay were of west African origin. It was possible to obtain sequences for 2 of these isolates which were identical and highlighted 3 and 1 nucleotide substitutions with the forward primers and reverse primers, respectively. Figure 3 also shows the sequences of 2 SAT 2 isolates (which generated borderline C T values in the 5ЈUTR assay), which have further nucleotide mismatches with the probe and primers. For the 3D RT-PCR target, 6 sequences were obtained from A, C, and NVD samples. All these sequences revealed nucleotide mismatches that might explain the poor performance of these samples in the 3D rRT-PCR assay. Retrospective rRT-PCR analysis of cell culture supernatant derived from in vitro passage of 1 of these isolates (A BHU 41/2002) showed that this material (presumably containing a higher amount of virus than the ES) could be detected by the assay, although the C T value generated was higher (33.36) than the corresponding value (17.25) of the 5ЈUTR assay (NB: higher C T values denote lower signal in the rRT-PCR).
Analysis of the mean differences in C T between the 2 assays for samples was performed to assess whether there was any serotype bias in either of the rRT-PCRs. When all the samples were analyzed together, this analysis ( Table 1) showed that the overall difference between the 2 assays was not significant. However, there were significant differences in mean C T values between the 2 assays at the serotype level. In particular, the 5ЈUTR assay performed less well against FMD viruses of the SAT serotypes (as previously reported 1 ), whereas serotype A viruses produced proportionally less signal in the 3D rRT-PCR. These differences can also be seen in the scatter plots in Fig. 1 . It is possible to speculate that the relatively poor signal reflects the presence of further nucleotide changes in the primer or probe sites (in addition to those described above), which leads to a reduced efficiency of the assay but not to a complete loss of signal. As might be Figure 2 . Summary of the results generated by the 2 real-time reverse transcription-polymerase chain reaction (rRT-PCR) assays for epithelium samples (n ϭ 394). Borderline results that fell between the cut-off cycle threshold (C T ) value defined for the respective rRT-PCR assays and absolute negative (no C T ) are tallied in the middle gray boxes. For instance, 23 samples that were positive by using the 3D assay gave a borderline reading with the 5Ј untranslated region (5ЈUTR) rRT-PCR. NB: the 5ЈUTR rRT-PCR uses a more conservative cut-off (C T Ͻ 40) than that used for the 3D rRT-PCR assay (C T Ͻ 45). ‡ Samples that gave a negative result (no C T ) in either or both rRT-PCR assays were excluded from this analysis. § Calculated by subtracting the C T value of the 5ЈUTR assay from the 3D assay. Cycle threshold values are inversely proportional to signal in the rRT-PCR; therefore, positive and negative numbers in this column represent increased signal for the 5ЈUTR or 3D rRT-PCR assays, respectively. expected, some of the viruses that were poorly detected in either of the assays were closely related to each other, suggesting that common sequence mismatches were present. However, the serotype A viruses that performed poorly in the 3D rRT-PCR were from at least 4 unrelated phylogenetic groups (determined by analysis of VP1 sequences held at IAH).
In this study, although VI and Ag-ELISA assays for FMDV were not performed at the same time as the rRT-PCR, it is possible to get some indication as to the performance of the rRT-PCR in comparison with these established assays, which many researches consider to be the ''gold standard.'' Using data from samples where the ES were prepared at the time of sample receipt (n ϭ 320), the sensitivity values were 95.4% for the 5ЈUTR and 97.7% for the 3D rRT-PCR. Positive rRT-PCR results were also obtained for a number of the samples that were originally classified as negative by VI and Ag-ELISA (as shown in the NVD plot in Fig. 1 ). These results, which show that rRT-PCRs can detect FMDV in samples that are negative by VI and Ag-ELISA, are consistent with findings from a previous study. 10 They probably reflect that molecular methods have high analytical sensitivity and will detect FMDV even if the samples are of poor quality and do not contain live virus. A consequence of the superior performance of the rRT-PCR assays is that very low specificity values are generated for both assays (33.3% for the 5ЈUTR and 38.6% for the 3D rRT-PCR assays), suggesting that caution should be placed on the use of VI and Ag-ELISA as a gold standard for FMDV diagnosis. In contrast to the NVD samples, only 4 of the 334 samples that were originally reported as positive by a combination of VI and Ag-ELISA failed to produce a signal in either of the rRT-PCR assays. Two of these samples were recategorized for this analysis as NVD because repeat attempts to isolate virus from the original ES failed, suggesting that the samples either had degraded or had been incorrectly labeled. The third sample (serotype O GRE 1/96) was positive by Ag-ELISA but not by VI or by either rRT-PCR method. The fourth sample (serotype O IRQ 5/ 94) was originally VI positive, but insufficient archived sample was available to attempt reisolation.
In summary, the overall performance of the 2 rRT-PCR assays was similar. This current investigation using approximately 400 samples consisting of clinical material from suspect cases of FMD expands on a study previously carried out at the Australian reference laboratory for FMD, 1 where both 5ЈUTR and 3D assays were tested on a small selection of inactivated viruses. These results emphasize the importance of creating depth and diversity in assay systems used to detect economically important diseases such as FMD. This study suggests that using both of these rRT-PCR assays (recognizing independent regions of the FMD viral genome) in concert would increase D-SN in a suspect FMD sample. This would decrease the likelihood of a false-negative result secondary to sequence variability and add additional validity to the final diagnosis. Parallel and multiplex rRT-PCRs exploiting these improved assay characteristics are currently under development. However, even when used independently, these rRT-PCR assays offer superior sensitivity over established diagnostic tests. This report provides further confidence in the use of this method for routine diagnosis of FMD and re-emphasizes the effectiveness of rRT-PCR as a diagnostic tool for routine FMD detection and control.
